Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 4/20 | 0.48 |
| ▸ | LAP3 | P28838 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.30 |
| ▸ | ANPEP | P15144 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL282484 | 0.97 | FDPS (0.50) | FDPSLAP3CA2GGPS1ANPEP | |
| Water SCHEMBL5697421 | 0.94 | FDPS (0.48) | FDPSLAP3CA2GGPS1ANPEP | |
| SCHEMBL11572545 | 0.94 | FDPS (0.48) | FDPSLAP3CA2GGPS1ANPEP | |
| SCHEMBL1185951 | 0.78 | FDPS (0.50) | FDPSLAP3CA2GGPS1ANPEP | |
| SCHEMBL61410 | 0.69 | FDPS (0.48) | FDPSLAP3CA2ANPEPKDM4E | |
| SCHEMBL11656003 | 0.69 | FDPS (0.42) | FDPS | |
| SCHEMBL13395519 | 0.69 | FDPS (0.61) | FDPSLAP3GGPS1MMP2 | |
| SCHEMBL11653622 | 0.69 | FDPS (0.42) | FDPSANPEP | |
| SCHEMBL11312086 | 0.69 | FDPS (0.42) | FDPS | |
| SCHEMBL743810 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0068584-A1 | Boron containing polyphosphonates for the treatment of calcific tumors | THE PROCTER & GAMBLE COMPANY (US) | 1983-01-05 | — | — | EP | disclosed |